D75.83

Clinical Causes: Primary thrombocytosis (essential thrombocythemia), where the bone marrow produces too many platelets without a clear reason. Secondary or reactive thrombocytosis, often caused by conditions such as infections, inflammation, iron deficiency anemia, or recent surgery. Splenectomy (surgical removal of the spleen), which can cause platelet levels to rise. Certain cancers, including lung, gastrointestinal, and ovarian cancers. Chronic inflammatory diseases like rheumatoid arthritis or inflammatory bowel disease. Blood disorders such as myeloproliferative neoplasms. Medications that stimulate platelet production, like certain chemotherapeutic agents.

Key Symptoms: Often no symptoms are present in mild cases. Unusual blood clotting, leading to deep vein thrombosis or pulmonary embolism. Headaches or dizziness. Chest pain or numbness and tingling in the extremities. Visual disturbances. Splenomegaly, or an enlarged spleen. Bleeding tendencies due to abnormal platelet function.

Diagnosis Path: Diagnosing thrombocytosis typically involves blood tests, primarily a complete blood count (CBC), which measures platelet levels. Persistent high platelet counts may lead healthcare providers to conduct additional assessments, such as bone marrow biopsies or genetic testing, to determine the underlying cause. Imaging studies might also be employed to evaluate for organ enlargement or other associated conditions. Accurate diagnosis distinguishes primary from secondary thrombocytosis, guiding appropriate treatment strategies.

Treatment Protocols: Management of thrombocytosis depends on its type and severity. Mild cases often require observation and regular monitoring. For cases where clotting risks are high or symptoms are significant, treatment options include: